Ownership history in COMMONWEALTH EQUITY SERVICES, LLC · 8 quarters on record
This page tracks every 13F SEC filing in which COMMONWEALTH EQUITY SERVICES, LLC reported a position in VERONA PHARMA PLC (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 13,336 | -1,214 | -8.3% | 0.00% | $1.4M | — |
| 2025 Q2 | REDUCED | 14,550 | -1,000 | -6.4% | 0.00% | $1.4M | — |
| 2025 Q1 | ADDED | 15,550 | +740 | +5.0% | 0.00% | $987K | — |
| 2024 Q4 | REDUCED | 14,810 | -681 | -4.4% | 0.00% | $688K | — |
| 2024 Q3 | ADDED | 15,491 | +3,531 | +29.5% | 0.00% | $446K | — |
| 2023 Q2 | REDUCED | 11,960 | -11,729 | -49.5% | 0.00% | $253K | — |
| 2023 Q1 | ADDED | 23,689 | +11,180 | +89.4% | 0.00% | $475K | — |
| 2022 Q4 | INITIATED | 12,509 | — | — | 0.00% | $326K | — |
As of 2025 Q3 — sorted by position size